Key facts
- HidraMed Solutions’s last known valuation is $22.0M (Jun 2025).
- It has raised $4.4M; the latest was Later Stage VC ($2.2M) in Jun 2025.
- Notable investors include Enterprise Ireland, Elkstone, Visa, Western Development Commission, EIT Health — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for HidraMed Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for HidraMed Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HidraMed Solutions
Provider of a wound dressing kit intended to help people suffering from Hidradenitis Suppurativa. The company's kit improves the wound care routine by permitting patients to self-manage their wounds in a trouble-free, prompt, and effective manner with wounds in difficult-to-dress areas of the body, enabling patients to enjoy an improved quality of life and providing them with confidence in the ability of the dressing to stay in place and not leak.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2016
- Employees
- 6
- Website
- hidramedsolutions.com/
- Ownership
- Privately Held (backing)
HidraMed Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HidraMed Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HidraMed Solutions in its N-PORT filings yet. We sweep new filings monthly.